2016
DOI: 10.3892/ijo.2016.3725
|View full text |Cite
|
Sign up to set email alerts
|

Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells

Abstract: Colorectal cancer (CRC) is one of the most aggressive cancers worldwide. Several anticancer agents are available to treat CRC, but eventually cancer relapse occurs. One major cause of chemotherapy failure is the emergence of drug-resistant tumor cells, suspected to originate from the stem cell compartment. The aim of this study was to ask whether drug resistance was associated with the acquisition of stem cell-like properties. We isolated drug-resistant derivatives of two human CRC cell lines, HT29 and HCT116,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
39
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(43 citation statements)
references
References 66 publications
(66 reference statements)
3
39
0
1
Order By: Relevance
“…Suppression of survivin contributed by increasing drug sensitivity to HSP90 inhibitor agents in HT-29 cells( 36 ). However, HT-29 compared with HCT-116 had higher expression levels of EPHB2, ITGβ-1, and Myc; overexpression of these genes is related to the acquisition of anticancer drug resistance( 37 ). To the best of the authors' knowledge, no study has reported the effects of 17AAG/oxaliplatin/capecitabine triple combinations in any cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…Suppression of survivin contributed by increasing drug sensitivity to HSP90 inhibitor agents in HT-29 cells( 36 ). However, HT-29 compared with HCT-116 had higher expression levels of EPHB2, ITGβ-1, and Myc; overexpression of these genes is related to the acquisition of anticancer drug resistance( 37 ). To the best of the authors' knowledge, no study has reported the effects of 17AAG/oxaliplatin/capecitabine triple combinations in any cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…In CRC, it is well established the transcriptional activation of certain genes such as c-Myc and Cyclin D, which are two positive cell cycle regulators associated with tumor intestinal cells proliferation (El Khoury et al, 2016). In vitro we previously demonstrated that PTHrP increases the amount of these proteins in tumor intestinal cells (Martín et al, 2014) and herein we showed that the hormone also up-regulates Cyclin D protein expression in vivo; furthermore, this peptide positively modulates cell cycle progression and changes the expression of other proteins involved in cell cycle regulation via MAPK pathway (Calvo et al, 2014).…”
Section: The Expression Changes Of C-myc and Cyclin D1 Induced By Pthmentioning
confidence: 99%
“…Since MDR is the major cause for the reduced effects of chemotherapy, MDR cells lines were used for the identification of novel antitumor compounds. [29] In order to find the best strategy for selecting the suitable agents for chemo-resistant tumors, in this research we used three different colon cancer cell lines and first we established the resistance of these cells using increasing concentrations of the anticancer drug, 5-FU. The results showed that Caco-2 cells were less resistant to this anticancer drug, while the other two lines could be used as models for the MDR colon cell lines.…”
Section: Cytotoxic Activitymentioning
confidence: 99%